Stock SEQUA SEQUANA MEDICAL N.V.
Add to a list
To use this feature you must be a member
Log inSign up

All News Sequana Medical N.V.

Equities

SEQUA

BE0974340722

Real-time Euronext Bruxelles
Other stock markets
 06:04:04 2024-05-02 am EDT 		5-day change 1st Jan Change
1.435 EUR +1.06% Intraday chart for Sequana Medical N.V. +1.41% -64.12%
Apr. 03 Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure CI
Mar. 28 Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sequana Medical N : Draft Remuneration Policy
PU
Advice of the ad hoc committee of independent directors in accordance with Article 7:179 of the Belgian Companies and Associations Code
PU
Report of the Board of Directors in accordance with Articles 7:179 and 7:197 of the Belgian Companies and Associations Code
PU
Special Report of the Board of Directors in accordance with Article 7:199 of the Belgian Companies and Associations Code
PU
Sequana Medical N : Report of the Board of Directors on the annual accounts for the year ended 31 December 2023
PU
Sequana Medical N : Statutory annual accounts for the year ended 31 December 2023
PU
Sequana Medical N : Statutory auditor’s report on the consolidated accounts for the year ended 31 December 2023
PU
Sequana Medical N : Statutory auditor’s report on the annual accounts for the year ended 31 December 2023
PU
Sequana Medical Announces Strong Data from DSR Proof-of-Concept Studies in Heart Failure Published in European Journal of Heart Failure
CI
Sequana Medical NV Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sequana Medical NV Announces Three Month Follow-Up Data from MOJAVE Non- Randomized Cohort Confirming Significant Improvement in Diuretic Response and Virtual Elimination of Loop Diuretics Following DSR Therapy
CI
Sequana Medical Raises EUR11.5 Million via Share Placement
MT
Sequana Medical's Premarket Application for Alfapump Accepted by US FDA; Shares Rise
MT
Sequana Medical Receives New US Reimbursement Codes for Alfapump System
MT
Sequana Medical submits Premarket Approval application to US FDA for alfapump in recurrent or refractory ascites due to liver cirrhosis
AQ
Belgium's Sequana Medical Seeks US FDA Premarket Approval for Liver Ascites Treatment Device
MT
Sequana Medical N : announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
PU
Sequana Medical NV Announces Positive Data from Non- Randomized Cohort in US Phase 1/2a MOJAVE Study of DSR® 2.0 for Treatment of Heart Failure
CI
Sequana Medical NV Appoints Ids Van Der Weij as Non-Executive Director
CI
Certain Shares of Sequana Medical NV are subject to a Lock-Up Agreement Ending on 22-OCT-2023.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SEQUA Stock
  4. News Sequana Medical N.V.